n = 15
n = 49
RR, 0.31 (95% CI, 0.17-0.55), P <.0001†
Bleeding outcome | Apixaban | Enoxaparin/Warfarin | ||
---|---|---|---|---|
Patients w/Event (no.) |
Event rate (%/y) |
Patients w/Event (no.) |
Event rate (%/y) |
|
Fatal bleeding‡ |
1 | <0.1 | 2 | 0.1 |
Nonfatal major bleeding at a critical site |
4 | 0.1 | 14 | 0.5 |
Other nonfatal major bleeding |
10 | 0.4 | 33 | 1.2 |